| 书目名称 | Nanomaterials in Pharmacology | | 编辑 | Zheng-Rong Lu,Shinji Sakuma | | 视频video | | | 概述 | Examines nanomaterials as a new therapeutic regimen in treating human diseases.Features practical approaches to this area of study.Includes contributions from experts in the field with key implementat | | 丛书名称 | Methods in Pharmacology and Toxicology | | 图书封面 |  | | 描述 | .This detailed volume aims to introduce nanomaterials as a new therapeutic regimen in treating human diseases. Divided into four sections, it explores inorganic nanomaterials, organic nanomaterials, pharmaceutical properties of nanomaterials, and applications of nanomaterials in medicine. Several examples of inorganic and organic nanomaterials are provided to demonstrate how to design and develop nanomaterials for pharmacological purposes. The key pharmaceutical properties, including biocompatibility, tissue interaction, pharmaceutics, and pharmacokinetics of nanomaterials are discussed with a focus on the safety and pharmaceutical considerations of nanomaterials in translational development. The pharmacological applications of nanomaterials are depicted in treating various human diseases, including cancer, cardiovascular diseases, immune disorders, infectious diseases, gastrointestinal disorders, bone diseases, respiratory disorders, and drug delivery. Written for the .Methods in Pharmacology and Toxicology. series, chapters include the kind of specifics and practical advice that ensures a smooth transition into the lab..Authoritative and enlightening, .Nanomaterials in Pharmacolo | | 出版日期 | Book 2016 | | 关键词 | Inorganic nanomaterials; Nanomedicine; Nanosized drug delivery systems; Nanotechnology; Organic nanomate | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-4939-3121-7 | | isbn_softcover | 978-1-4939-4955-7 | | isbn_ebook | 978-1-4939-3121-7Series ISSN 1557-2153 Series E-ISSN 1940-6053 | | issn_series | 1557-2153 | | copyright | Springer Science+Business Media New York 2016 |
The information of publication is updating
|
|
发表于 2025-3-21 17:38:50
